Agent Skills
› brycewang-stanford/Awesome-Journal-Skills
› cc-structured-abstract
cc-structured-abstract
GitHub专为Cancer Cell期刊撰写Front Matter，包括摘要、亮点、eTOC简介及图形摘要。遵循Cell Press规范，强调机制叙事与证据校准，避免夸大宣传，确保内容准确、简洁且具影响力。
触发场景
需要撰写Cancer Cell的摘要（Summary）
需要生成Highlights短列表
需要编写eTOC blurb
构建或优化图形摘要
安装
npx skills add brycewang-stanford/Awesome-Journal-Skills --skill cc-structured-abstract -g -y
SKILL.md
Frontmatter
{
"name": "cc-structured-abstract",
"description": "Use when writing the Cancer Cell (Cell Press) front matter — the Summary, eTOC blurb, Highlights, and graphical abstract. It crafts these short items for accuracy and impact; it does not write Results or calibrate statistics."
}
Summary, Highlights & Graphical Abstract (cc-structured-abstract)
When to trigger
- Need a Cancer Cell Summary (the abstract)
- Need Highlights (the short bullet list Cell Press requires)
- Need the eTOC blurb (one-paragraph teaser for the table of contents)
- Building or refining the graphical abstract
The Summary (abstract)
Cell Press uses a single-paragraph Summary (verify the current word limit on the author page). Structure it as a tight mechanistic arc:
- Context / gap — the cancer problem and the unknown (1 sentence).
- Approach — the systems used (cells / in vivo / human), at a high level.
- Core finding — the mechanism: what regulates what, with direction.
- Validation — that it holds in vivo and/or in patient data.
- Significance — the translational implication (vulnerability / biomarker / therapy), calibrated to the evidence.
Lead with the discovery, not the background. Name the molecule/axis and the cancer context concretely. Avoid hype words ("novel," "unprecedented") and unsupported clinical promises.
Highlights
- Provide the required number of short bullets (commonly four; verify current count), each ~85 characters.
- Each highlight is a result, not a method or aim.
- Order them as a mini-story: key mechanism → validation → translational point.
- Make them specific and declarative ("X drives Y via Z in pancreatic tumors"), not vague ("X plays a role").
eTOC blurb
- One short paragraph (a few sentences) written for a broad cancer audience.
- Third person, present tense; names the authors' key finding and why it matters.
- Often written as "Author et al. show that ..." — confirm the current style.
- No abbreviations that a non-specialist would not know.
Graphical abstract
- One panel that conveys the mechanism and its consequence at a glance.
- Show the axis (input → node → output) and the tumor context; minimal text.
- Must match the paper's actual claims — no implied results beyond the data.
- Build in BioRender/Illustrator at required resolution; legible at thumbnail size.
Checklist
- Summary leads with the discovery and names the mechanism concretely
- Summary states orthogonal validation (in vivo / human) and a calibrated significance line
- Summary within the current word limit; no hype words
- Highlights are results, specific, ordered as a story, within length
- eTOC blurb is broad-audience, present tense, accurate
- Graphical abstract shows mechanism → consequence and matches the data
- Front matter is consistent with the paper's actual claims and
n/evidence
Anti-patterns
- Background-heavy Summary that buries the finding
- Highlights that restate aims/methods or are vague
- Overclaiming therapeutic impact in the Summary or graphical abstract
- Graphical abstract implying results not shown in the paper
- eTOC blurb stuffed with jargon and abbreviations
- Inconsistent gene/protein nomenclature across front matter and text
Abstract pass for Cancer Cell
Use this as a second-pass capability check. First lock the cancer context, mechanism, model system, validation chain, and translational boundary; then test whether the manuscript addresses cancer-biology reviewers who expect mechanistic oncology, translational relevance, and strong multi-modal validation.
- Primary move: Compress to question, design, population/object, result, limitation, and contribution; remove generic importance sentences.
- Decision ledger: return
claim / evidence / blocker / next editrows so the next pass can patch the manuscript directly. - Neighbor test: compare against Cell for broader biology, Nature Cancer for oncology breadth, Clinical Cancer Research for clinical translation; if the neighboring outlet has the stronger audience claim, recommend re-routing before polishing.
- Verification floor: before submission-ready advice, re-open
resources/official-source-map.mdfor volatile rules and name the one unresolved fact that could change the recommendation.
Output format
【Summary】drafted; words = ...; leads with finding? Y/N
【Validation line】in vivo / human stated? Y/N
【Highlights】n bullets; all results? within length?
【eTOC blurb】broad-audience? accurate? Y/N
【Graphical abstract】mechanism→consequence? matches data? Y/N
【Overclaim check】hype/clinical promises removed? Y/N
【Next step】cc-ethics-registration or cc-writing-style
版本历史
- 1839142 当前 2026-07-05 12:26
